Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Favorable phase I data presented for Bay-43-9006 at ASCO

May 30, 2001

Telik begins phase II trial of TLK-286 for treatment of ovarian cancer

May 30, 2001

First human results for rhAngiostatin support its further development

May 29, 2001

NK-30424 analogues useful as antitumor and antiinflammatory agents

May 28, 2001

Investigational anticancer agent phenoxodiol enters first U.S. trial

May 28, 2001

Tyrosine kinase inhibitors useful for immunological disorders and cancer

May 25, 2001

Nonpeptide inhibitors of methionyl aminopeptidase useful for angiogenesis-related conditions

May 25, 2001

Revived hope for tesmilifene in breast cancer at YM BioSciences

May 25, 2001

Findings from first phase I clinical trial of Panzem presented at ASCO meeting

May 25, 2001

Hybrigenics and Institut Curie open laboratory for cancer proteomics research

May 25, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026